SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899866-17-000168
Filing Date
2017-09-22
Accepted
2017-09-22 16:59:03
Documents
1
Period of Report
2017-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_150611384790317.html 3  
1 FORM 3 wf-form3_150611384790317.xml 3 1701
  Complete submission text file 0000899866-17-000168.txt   3054
Mailing Address 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address 100 COLLEGE STREET NEW HAVEN CT 06510 2032722596
ALEXION PHARMACEUTICALS INC (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27756 | Film No.: 171098097